BioSante (BPAX) Enters $3.48M Registered Direct Offering

August 17, 2012 9:32 AM EDT Send to a Friend
Get Alerts BPAX Hot Sheet
Trade BPAX Now!
BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) has received a commitment from an institutional investor to purchase $3,475,000 of securities in a registered direct offering.

BioSante expects to receive net proceeds of approximately $3.3 million after deducting placement agent fees and other offering expenses. BioSante has entered into a securities purchase agreement with this investor pursuant to which BioSante has agreed to sell 2,359,932 shares of its common stock and warrants to purchase up to 1,179,966 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.5 of a share of common stock, will be sold for a purchase price of $1.4725, a premium to the closing price on the day before pricing.

Rodman & Renshaw, LLC is acting as the exclusive placement agent for the transaction.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Corporate News, Equity Offerings

Related Entities

Rodman & Renshaw

Add Your Comment